Drug
Atrovent® - inhalets
Atrovent® - inhalets is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(5)
Detailed Status
Completed5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Trials by Status
completed5100%
Recent Activity
0 active trials
Showing 5 of 5
completed
Postmarketing Surveillance of Atrovent® in Chronic Obstructive Pulmonary Disease
NCT02238158
completed
Postmarketing Surveillance Study of Atrovent® Inhalets in Chronic Obstructive Airways Disease
NCT02238132
completed
Postmarketing Surveillance Study of Atrovent® Inhalets in Chronic Obstructive Pulmonary Disease
NCT02238171
completed
Post-marketing Surveillance of Atrovent® Inhalets in Chronic Obstructive Pulmonary Disease
NCT02233894
completed
Post-marketing Surveillance of Atrovent® in Chronic Obstructive Pulmonary Disease
NCT02233881
Clinical Trials (5)
Showing 5 of 5 trials
NCT02238158
Postmarketing Surveillance of Atrovent® in Chronic Obstructive Pulmonary Disease
NCT02238132
Postmarketing Surveillance Study of Atrovent® Inhalets in Chronic Obstructive Airways Disease
NCT02238171
Postmarketing Surveillance Study of Atrovent® Inhalets in Chronic Obstructive Pulmonary Disease
NCT02233894
Post-marketing Surveillance of Atrovent® Inhalets in Chronic Obstructive Pulmonary Disease
NCT02233881
Post-marketing Surveillance of Atrovent® in Chronic Obstructive Pulmonary Disease
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5